I-BET151 (GSK1210151A) synthesis
- Product Name:I-BET151 (GSK1210151A)
- CAS Number:1300031-49-5
- Molecular formula:C23H21N5O3
- Molecular Weight:415.44
1300737-69-2
2 suppliers
inquiry
1300031-49-5
139 suppliers
$35.00/1mg
Yield: 77%
Reaction Conditions:
with [bis(acetoxy)iodo]benzene;potassium hydroxide in methanol for 1.33333 h;Cooling with ice;Hofmann rearrangement;
Steps:
7-(3,5-dimethyl-4-isoxazolyl)-8-(methyloxy)-1-[(1R)-1-(2-pyridinyl)ethyl]-1,3-dihydro-2-Himidazo[4,5c]quinolin-2-one (I-BET151)
7-(3,5-Dimethyl-4-isoxazolyl)-6-(methyloxy)-4-{[(1R)-1-(2-pyridinyl)ethyl]amino}-3-quinolinecarboxamide (45 g, 102 mmol) was dissolved in methanol (500 mL) and potassium hydroxide (7.47 g, 133 mmol) was added. The mixture was stirred in an ice bath, then iodobenzene diacetate (39.6 g, 123 mmol) was added in small portions over 20 min and the mixture stirred for a further 1 h. The solvent was evaporated in vacuo, the residue diluted with water (1 L), and the resulting gummy suspension extracted with DCM (2 x 300 mL). The solvent was dried (sodium sulphate) and loaded directly onto a silica column (750 g), which was then eluted with a 2M ammonia in methanol / DCM gradient (0-10%). After evaporation of solvents in vacuo 7-(3,5-dimethyl-4-isoxazolyl)-8-(methyloxy)-1-[(1R)-1-(2-pyridinyl)ethyl]-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one (32.7 g, 77% yield) was obtained as a beige solid. 1H-NMR (600 MHz, DMSO-d6) d ppm 2.03 (d, J=6.5 Hz, 3 H), 2.04 (s, 3 H), 2.25 (s, 3 H), 3.46 (bs, 3 H), 6.26 (q, J=7.1 Hz, 1 H), 6.69 (bs, 1 H), 7.35 (dd, J=7.0, 5.1 Hz, 1 H), 7.41 (d, J=6.6 Hz, 1 H), 7.76-7.79 (m, 1 H), 7.79 (s, 1 H), 8.59-8.65 (m, 2 H), 11.77 (bs, 1H). 13C NMR (151 MHz, DMSO-d6) d ppm 10.3, 11.3, 17.6, 51.8, 55.5, 100.8, 112.0, 115.4, 120.2, 121.0, 122.7, 122.7, 128.1, 132.3, 132. 8, 137.6, 139.8, 149.3, 154.3, 154.5, 159.0, 159.2, 166.0. MS (Method HpH): MH+ 416, Rt 0.85 min. HRMS (m/z): [MH]+ calcd for C23H22N5O3 416.1723; found 416.1718.
References:
Mirguet, Olivier;Lamotte, Yann;Donche, Frédéric;Toum, Jér?me;Gellibert, Franoise;Bouillot, Anne;Gosmini, Romain;Nguyen, Van-Loc;Delannée, Delphine;Seal, Jonathan;Blandel, Florence;Boullay, Anne-Bénédicte;Boursier, Eric;Martin, Sandrine;Brusq, Jean-Marie;Krysa, Gael;Riou, Alizon;Tellier, Rémi;Costaz, Agns;Huet, Pascal;Dudit, Yann;Trottet, Lionel;Kirilovsky, Jorge;Nicodeme, Edwige [Bioorganic and Medicinal Chemistry Letters,2012,vol. 22,# 8,p. 2963 - 2967] Location in patent:supporting information; experimental part
16114-47-9
260 suppliers
$6.00/250mg
1300031-49-5
139 suppliers
$35.00/1mg
5399-03-1
135 suppliers
$8.00/1g
1300031-49-5
139 suppliers
$35.00/1mg
1300031-62-2
1 suppliers
inquiry
1300031-49-5
139 suppliers
$35.00/1mg
1300031-61-1
1 suppliers
inquiry
1300031-49-5
139 suppliers
$35.00/1mg